Mirati Therapeutics (MRTX) : Aviva Holdings Ltd. scooped up 1,023,501 additional shares in Mirati Therapeutics during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 15, 2016. The investment management firm now holds a total of 1,546,001 shares of Mirati Therapeutics which is valued at $8,425,705.Mirati Therapeutics makes up approximately 5.99% of Aviva Holdings Ltd.’s portfolio.
Other Hedge Funds, Including , Pdt Partners sold out all of its stake in MRTX during the most recent quarter. The investment firm sold 18,600 shares of MRTX which is valued $101,370. Trexquant Investment Lp added MRTX to its portfolio by purchasing 48,178 company shares during the most recent quarter which is valued at $262,570. Mirati Therapeutics makes up approx 0.03% of Trexquant Investment Lp’s portfolio. Tocqueville Asset Management sold out all of its stake in MRTX during the most recent quarter. The investment firm sold 11,950 shares of MRTX which is valued $55,448. Simplex Trading added MRTX to its portfolio by purchasing 71 company shares during the most recent quarter which is valued at $361.
Mirati Therapeutics opened for trading at $5.03 and hit $5.21 on the upside on Thursday, eventually ending the session at $5.18, with a gain of 2.57% or 0.13 points. The heightened volatility saw the trading volume jump to 71,271 shares. Company has a market cap of $103 M.
Many Wall Street Analysts have commented on Mirati Therapeutics. Mirati Therapeutics was Downgraded by Jefferies to ” Hold” on Jun 6, 2016. Shares were Reiterated by Wedbush on Jun 6, 2016 to “Outperform” and Lowered the Price Target to $ 27 from a previous price target of $29 .Mirati Therapeutics was Downgraded by Leerink Partners to ” Mkt Perform” on Jun 6, 2016.